Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

PTN

PALATIN TECHNOLOGIES INC

Pharmaceutical Preparations · SIC 2834CIK 911216Held by 1 tracked managerEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2026
$13.0M
Net Income FY2026
$(8.0M)
EPS (Basic, as reported)
$-2.96
Net Margin FY2026
-63.5%
ROE FY2026
-125.3%
Total Equity
$7.0M
Shares Out
2M
Business description

PALATIN TECHNOLOGIES INC — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2010–FY2026; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 45 → 13 -12.9% CAGR
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022⚑FY2023FY2024⚑FY2025⚑FY2026
Revenue45676000154013
Cost of revenue———00000——
Research & development(46)(33)(15)(14)(13)(21)(23)(22)(15)(12)
Selling, general & administrative—————(17)(15)(12)(8)—
General & administrative(10)(9)(10)(10)(17)(17)——(8)(9)
Total operating expenses(55)(41)(25)(24)(33)(38)(37)(27)(17)(22)
Operating income(11)2636(24)(33)(37)(32)(22)(17)(9)
Interest expense(2)(1)00000000
Interest & investment income00010—————
Other income (expense), net(2)(1)01000(7)00
Pre-tax income—————(36)(32)———
Income tax expense0000—0(5)(30)(17)(8)
Net income(13)2536(22)(34)(36)(28)(30)(17)(8)
EPS — basic($0.07)$0.12$0.17($0.10)——($2.21)($2.02)($32.15)($2.96)
EPS — diluted($0.07)$0.12$0.16($0.10)————($32.15)($2.96)
Shares outstanding — basic (M)184198208235——111513
Shares outstanding — diluted (M)184207217235———013

Showing the latest 10 of 17 fiscal years.

  • ⚑ Weighted-average shares changed ÷20.00 between FY2020 and FY2023 — likely a reverse split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ÷14.29 between FY2024 and FY2025 — likely a reverse split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×3.00 between FY2025 and FY2026 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.